These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28346435)

  • 1. AAV9-mediated engineering of autotransplanted kidney of non-human primates.
    Tomasoni S; Trionfini P; Azzollini N; Zentilin L; Giacca M; Aiello S; Longaretti L; Cozzi E; Baldan N; Remuzzi G; Benigni A
    Gene Ther; 2017 May; 24(5):308-313. PubMed ID: 28346435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.
    Angin M; Poirier N; Dilek N; Le Guiner C; Toromanoff A; Blancher A; Cherel Y; Deschamps JY; Tillou X; Renaudin K; Minault D; Hervouet J; Blancho G; Vanhove B; Anegon I; Le Mauff B
    Transpl Immunol; 2012 Dec; 27(4):139-45. PubMed ID: 23098770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
    Oshima S; Karrer EE; Kawato Y; Maeda M; Fukahori H; Tsujimoto S; Hirose J; Nakamura K; Marui T; Takamura F; Noto T; Chapin SJ; Fujii Y; Neighbors M; Viswanathan S; Devens BH; Higashi Y
    Transplantation; 2016 Dec; 100(12):2611-2620. PubMed ID: 27861289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo intracoronary gene transfer of adeno-associated virus 2 leads to superior transduction over serotypes 8 and 9 in rat heart transplants.
    Raissadati A; Jokinen JJ; Syrjälä SO; Keränen MA; Krebs R; Tuuminen R; Arnaudova R; Rouvinen E; Anisimov A; Soronen J; Pajusola K; Alitalo K; Nykänen AI; Lemström K
    Transpl Int; 2013 Nov; 26(11):1126-37. PubMed ID: 24102821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of allospecific gene-engineered T cells in transplantation gene therapy: specific T cell activation determines transgene expression in vitro and in vivo.
    Hammer MH; Flügel A; Seifert M; Lehmann M; Brandt C; Volk HD; Ritter T
    Hum Gene Ther; 2000 Jun; 11(9):1303-11. PubMed ID: 10890740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The protective effects on allografts of adeno-associated heme-oxygenase-1 gene therapy against chronic rejection injury].
    Gong NQ; Du DF; Dong C; Chen XL; Guo H; Xiao JS; Zhang WJ; Lin ZB; Chen ZS; Ye QF; Xia SS
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):254-7. PubMed ID: 17502023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
    Huszthy PC; Svendsen A; Wilson JM; Kotin RM; Lønning PE; Bjerkvig R; Hoover F
    Hum Gene Ther; 2005 Mar; 16(3):381-92. PubMed ID: 15812233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
    Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
    Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitous LEA29Y Expression Blocks T Cell Co-Stimulation but Permits Sexual Reproduction in Genetically Modified Pigs.
    Bähr A; Käser T; Kemter E; Gerner W; Kurome M; Baars W; Herbach N; Witter K; Wünsch A; Talker SC; Kessler B; Nagashima H; Saalmüller A; Schwinzer R; Wolf E; Klymiuk N
    PLoS One; 2016; 11(5):e0155676. PubMed ID: 27175998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated viral vector 2.9 thymosin ß4 application attenuates rejection after heart transplantation: results of a preclinical study in the pig.
    Postrach J; Schmidt M; Thormann M; Thein E; Burdorf L; Reichart B; Sotlar K; Walz C; Faber C; Bauer A; Schmoeckel M; Kupatt C; Hinkel R
    Transplantation; 2014 Oct; 98(8):835-43. PubMed ID: 25321165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
    Adriaansen J; Khoury M; de Cortie CJ; Fallaux FJ; Bigey P; Scherman D; Gould DJ; Chernajovsky Y; Apparailly F; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2007 Sep; 66(9):1143-50. PubMed ID: 17363402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo.
    Takeda S; Takahashi M; Mizukami H; Kobayashi E; Takeuchi K; Hakamata Y; Kaneko T; Yamamoto H; Ito C; Ozawa K; Ishibashi K; Matsuzaki T; Takata K; Asano Y; Kusano E
    Nephron Exp Nephrol; 2004; 96(4):e119-26. PubMed ID: 15122061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis.
    Smith JR; Verwaerde C; Rolling F; Naud MC; Delanoye A; Thillaye-Goldenberg B; Apparailly F; De Kozak Y
    Hum Gene Ther; 2005 Sep; 16(9):1037-46. PubMed ID: 16149902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
    Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
    J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
    Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
    Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.
    Harrington EA; Sloan JL; Manoli I; Chandler RJ; Schneider M; McGuire PJ; Calcedo R; Wilson JM; Venditti CP
    Hum Gene Ther; 2016 May; 27(5):345-53. PubMed ID: 26790480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.
    Simeoni E; Dudler J; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):222-8. PubMed ID: 17182252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.